CA2891316C - Human binding molecules having killing activity against enterococci and uses thereof - Google Patents

Human binding molecules having killing activity against enterococci and uses thereof Download PDF

Info

Publication number
CA2891316C
CA2891316C CA2891316A CA2891316A CA2891316C CA 2891316 C CA2891316 C CA 2891316C CA 2891316 A CA2891316 A CA 2891316A CA 2891316 A CA2891316 A CA 2891316A CA 2891316 C CA2891316 C CA 2891316C
Authority
CA
Canada
Prior art keywords
seq
binding
binding molecules
molecules
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2891316A
Other languages
English (en)
French (fr)
Other versions
CA2891316A1 (en
Inventor
Mark Throsby
Robert Arjen Kramer
Cornelis Adriaan De Kruif
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Vaccines and Prevention BV
Original Assignee
Janssen Vaccines and Prevention BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Vaccines and Prevention BV filed Critical Janssen Vaccines and Prevention BV
Priority claimed from CA2654502A external-priority patent/CA2654502C/en
Publication of CA2891316A1 publication Critical patent/CA2891316A1/en
Application granted granted Critical
Publication of CA2891316C publication Critical patent/CA2891316C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/116—Polyvalent bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA2891316A 2006-06-06 2007-06-05 Human binding molecules having killing activity against enterococci and uses thereof Active CA2891316C (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US81154206P 2006-06-06 2006-06-06
EP06115013.2 2006-06-06
US60/811,542 2006-06-06
EP06115013 2006-06-06
EP06116719.3 2006-07-06
EP06116719 2006-07-06
EP06121258 2006-09-26
EP06121258.5 2006-09-26
EP07103587 2007-03-06
EP07103587.7 2007-03-06
CA2654502A CA2654502C (en) 2006-06-06 2007-06-05 Human binding molecules having killing activity against enterococci and uses thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2654502A Division CA2654502C (en) 2006-06-06 2007-06-05 Human binding molecules having killing activity against enterococci and uses thereof

Publications (2)

Publication Number Publication Date
CA2891316A1 CA2891316A1 (en) 2007-12-13
CA2891316C true CA2891316C (en) 2020-07-21

Family

ID=45220170

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2891316A Active CA2891316C (en) 2006-06-06 2007-06-05 Human binding molecules having killing activity against enterococci and uses thereof

Country Status (5)

Country Link
KR (3) KR20180072676A (ru)
CN (1) CN102731651B (ru)
CA (1) CA2891316C (ru)
EA (1) EA021767B1 (ru)
NZ (3) NZ606828A (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10738342B2 (en) * 2018-08-30 2020-08-11 Urinary Technologies, Inc. System for microbial species detection, quantification and antibiotic susceptibility identification
CN113493510A (zh) * 2021-07-07 2021-10-12 上海交通大学 一种牛源抗金黄色葡萄球菌LukD毒力因子的单链抗体及其制备和应用
CN114196586B (zh) * 2021-12-20 2023-04-11 郑州大学 一株蒙氏肠球菌及其在发酵中草药中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610293B1 (en) * 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US6908994B1 (en) * 1999-05-10 2005-06-21 The Texas A&M University System Collagen-binding proteins from enterococcal bacteria
JP2005524624A (ja) * 2001-12-21 2005-08-18 バイオシネクサス インコーポレーテッド グラム陽性細菌のペプチドグリカンに対する多機能性モノクローナル抗体
JP2006502968A (ja) * 2002-02-21 2006-01-26 ユニヴエルシタ デリ スツディ ディ パヴィア 細菌性コラーゲン結合タンパク質に対して交差反応性のモノクロナール抗体

Also Published As

Publication number Publication date
KR20180072676A (ko) 2018-06-29
KR20170042376A (ko) 2017-04-18
EA021767B1 (ru) 2015-08-31
CN102731651B (zh) 2015-02-04
KR20160003317A (ko) 2016-01-08
EA201200182A1 (ru) 2012-06-29
NZ606828A (en) 2014-08-29
NZ594945A (en) 2013-03-28
NZ572775A (en) 2011-09-30
CA2891316A1 (en) 2007-12-13
CN102731651A (zh) 2012-10-17

Similar Documents

Publication Publication Date Title
CA2654502C (en) Human binding molecules having killing activity against enterococci and uses thereof
US8460666B2 (en) Human binding molecules having killing activity against staphylococci and uses thereof
CA2891316C (en) Human binding molecules having killing activity against enterococci and uses thereof
AU2012268821B2 (en) Human binding molecules having killing activity against staphylococci and uses thereof
IL237843A (en) Human binding molecules with Staphylococcus killing abilities, preparations containing them, method for their production and uses

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20150512

FZDE Discontinued

Effective date: 20170922

FZDC Discontinued application reinstated

Effective date: 20180504